Related Experiment Videos
DNA aptamers as potential anti-HIV agents
Shan-Ho Chou1, Ko-Hsin Chin, Andrew H-J Wang
1Institute of Biochemistry, National Chung-Hsing University, Taichung, Taiwan, Republic of China. shchou@nchu.edu.tw
Trends in Biochemical Sciences
|May 18, 2005
Summary
A novel DNA aptamer, 93del, forms a unique quadruplex structure and inhibits HIV-1 integrase. This G-rich aptamer shows potential as an anti-HIV-1 therapeutic by blocking essential enzyme residues.
Area of Science:
- Biochemistry
- Structural Biology
- Virology
Background:
- Guanine (G)-rich DNA sequences form stable G-quadruplex structures.
- Aptamers are DNA or RNA molecules with specific binding properties.
- HIV-1 integrase is a crucial enzyme for viral replication.
Purpose of the Study:
- To characterize a novel DNA aptamer (93del) with anti-HIV-1 integrase activity.
- To elucidate the structural basis for the aptamer's inhibitory mechanism.
- To explore the potential of G-quadruplex aptamers as antiviral agents.
Main Methods:
- DNA aptamer synthesis and characterization.
- G-quadruplex structure determination in potassium (K+) solution.
- In vitro anti-HIV-1 integrase activity assays.
- Molecular docking simulations to model the aptamer-integrase complex.
Main Results:
- The 93del aptamer adopts a novel dimeric quadruplex folding topology.
- The aptamer exhibits potent anti-HIV-1 integrase activity in the nanomolar range.
- Docking models reveal the aptamer binding within the integrase channel, blocking catalytic residues.
Conclusions:
- The 93del aptamer's unique G-quadruplex structure is key to its anti-HIV-1 integrase activity.
- The aptamer functions by sterically hindering essential catalytic sites of the integrase enzyme.
- G-quadruplex aptamers represent a promising strategy for developing novel anti-HIV-1 therapies.